Bentham Science Logo

Contents

Current Pharmaceutical Design, Volume 20 - Number 24





Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC

, 20(24): 3894 - 3900

Paolo Maione, Antonio Rossi, Marianna Bareschino, Paola Claudia Sacco, Clorinda Schettino, Francesca Casaluce, Assunta Sgambato and Cesare Gridelli


DOI: 10.2174/13816128113196660764


Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better...

, 20(24): 3901 - 3913

Massimo Di Maio, Alessandro Morabito, Maria Carmela Piccirillo, Gennaro Daniele, Pasqualina Giordano, Raffaele Costanzo, Claudia Sandomenico, Agnese Montanino, Gaetano Rocco and Francesco Perrone


DOI: 10.2174/13816128113196660762



Across the Universe of K-Ras Mutations in Non-Small-Cell-Lung Cancer

, 20(24): 3933 - 3943

Sheila Piva, Monica Ganzinelli, Marina Chiara Garassino, Elisa Caiola, Gabriella Farina, Massimo Broggini and Mirko Marabese


DOI: 10.2174/13816128113196660761


Signaling Intermediates (MAPK and PI3K) as Therapeutic Targets in NSCLC

, 20(24): 3944 - 3957

Ludovica Ciuffreda, Ursula Cesta Incani, Linda S. Steelman, Stephen L. Abrams, Italia Falcone, Anais Del Curatolo, William H. Chappell, Richard A. Franklin, Sabrina Vari, Francesco Cognetti, James A. McCubrey and Michele Milella


DOI: 10.2174/13816128113196660763


Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: 'A Hard Days Night'

, 20(24): 3958 - 3972

Sara Pilotto, Maria Bonomi, Francesco Massari, Michele Milella, Ludovica Ciuffreda, Matteo Brunelli, Matteo Fassan, Marco Chilosi, Aldo Scarpa, Giampaolo Tortora and Emilio Bria


DOI: 10.2174/13816128113196660757





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science